Glypican 3-targeted therapy in hepatocellular carcinoma

T Nishida, H Kataoka - Cancers, 2019 - mdpi.com
Glypican-3 (GPC3) is an oncofetal glycoprotein attached to the cell membrane by a
glycophosphatidylinositol anchor. GPC3 is overexpressed in some kinds of tumors …

The role of glypican-3 in regulating Wnt, YAP, and hedgehog in liver cancer

A Kolluri, M Ho - Frontiers in oncology, 2019 - frontiersin.org
Glypican-3 (GPC3) is a cell-surface glycoprotein consisting of heparan sulfate
glycosaminoglycan chains and an inner protein core. It has important functions in cellular …

Landscape of cancer diagnostic biomarkers from specifically expressed genes

Y Lv, SY Lin, FF Hu, Z Ye, Q Zhang… - Briefings in …, 2020 - academic.oup.com
Although there has been great progress in cancer treatment, cancer remains a serious
health threat to humans because of the lack of biomarkers for diagnosis, especially for early …

Systematic review of the immunological landscape of Wilms tumors

F Palmisani, H Kovar, L Kager, G Amann… - Molecular Therapy …, 2021 - cell.com
Results of immunotherapy in childhood solid cancer have been so far, with the exception of
neuroblastoma, quite disappointing. Lack of knowledge of the immune contexture of these …

[HTML][HTML] GPC3-Unc5 receptor complex structure and role in cell migration

O Akkermans, C Delloye-Bourgeois, C Peregrina… - Cell, 2022 - cell.com
Neural migration is a critical step during brain development that requires the interactions of
cell-surface guidance receptors. Cancer cells often hijack these mechanisms to disseminate …

The role of IGF/IGF-IR-signaling and extracellular matrix effectors in bone sarcoma pathogenesis

GN Tzanakakis, EM Giatagana, A Berdiaki, I Spyridaki… - Cancers, 2021 - mdpi.com
Simple Summary Bone sarcomas are mesenchymal origin tumors. Bone sarcoma patients
show a variable response or do not respond to chemotherapy. Notably, improving efficient …

Children's Oncology Group's 2023 blueprint for research: renal tumors

JI Geller, AL Hong, KL Vallance… - Pediatric Blood & …, 2023 - Wiley Online Library
Every year, approximately 600 infants, children, and adolescents are diagnosed with renal
cancer in the United States. In addition to Wilms tumor (WT), which accounts for about 80 …

Wnt/β-catenin signaling as a useful therapeutic target in hepatoblastoma

YL Sha, S Liu, WW Yan, B Dong - Bioscience reports, 2019 - portlandpress.com
Hepatoblastoma is a malignant tumor in the liver of children that generally occurs at the age
of 2–3 years. There have been ample evidence from the preclinical as well as clinical …

[HTML][HTML] Recent therapeutics in hepatocellular carcinoma

Z Fan, P Zhou, B Jin, G Li, L Feng… - American Journal of …, 2023 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is a malignant tumor of hepatocytes. It is a common
malignant tumor of the digestive system that often has initially hidden presentation followed …

Development of bispecific antibodies in China: overview and prospects

J Zhang, J Yi, P Zhou - Antibody therapeutics, 2020 - academic.oup.com
ABSTRACT A bispecific antibody (bsAb) can simultaneously bind two different epitopes or
antigens, allowing for multiple mechanistic functions with synergistic effects. BsAbs have …